Trial Search Results

A Novel Noninvasive Thermoregulatory Device for Postural Tachycardia Syndrome

The investigators hope to learn the feasibility and preliminary efficacy of the Embr device for improving thermal comfort in individuals with POTS and impaired thermoregulation. Feasibility will be assessed via usage of the Embr device and participant feedback. Preliminary efficacy measures will include temperature-related symptoms and temperature- related quality of life in individuals with POTS and impaired thermoregulation.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: Embr Labs, Inc.

Stanford Investigator(s):


  • Device: Embr Device




Inclusion Criteria:

   - Diagnosis of POTS

   - Participant self-report of heat or cold intolerance

   - Willingness to wear the Embr device for 3 weeks, charging the device daily, and

   - Have a working smartphone (iPhone 6 or greater; or Android 8.0 or greater

   - Comfortable downloading and using the companion app on their phone

   - Able to provide informed written consent

   - Able to complete written questionnaires

Exclusion Criteria:

   - Prior or current use of the study device

   - Hypohidrosis, hyperhidrosis, or anhidrosis, as determined by sudomotor testing;
   peripheral neuropathy; perimenopausal, menopausal, postmenopausal state; temperature
   intolerance due to other medical disorders (i.e. malignancy, systemic autoimmune

   - Medications known to affect sweat function

   - Non-English speaking

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting